Diaphorina citri psyllid: psy3092

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Retinoic acid receptor RXR-gamma	Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid.	very confident	Q0GFF6
Retinoic acid receptor RXR-gamma	Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid.	very confident	P28701
Retinoic acid receptor RXR-gamma	Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid.	very confident	Q5REL6

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0044464 [CC]	cell part	confident	GO:0005575, GO:0005623
GO:0003677 [MF]	DNA binding	confident	GO:0097159, GO:0003674, GO:1901363, GO:0003676, GO:0005488
GO:0004886 [MF]	9-cis retinoic acid receptor activity	confident	GO:0003708, GO:0038023, GO:0003700, GO:0001071, GO:0060089, GO:0003674, GO:0004879, GO:0004871, GO:0000981, GO:0004872
GO:0006357 [BP]	regulation of transcription from RNA polymerase II promoter	confident	GO:0009889, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0051252, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0010468
GO:0031641 [BP]	regulation of myelination	confident	GO:0051239, GO:0044057, GO:0031644, GO:0032844, GO:0008150, GO:0050793, GO:2000021, GO:2000026, GO:0051960, GO:0023051, GO:0065007, GO:0051969, GO:0010646, GO:0050789, GO:0050794
GO:0045892 [BP]	negative regulation of transcription, DNA-dependent	confident	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0010558, GO:0048523
GO:0044323 [MF]	retinoic acid-responsive element binding	probable	GO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0031490 [MF]	chromatin DNA binding	probable	GO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:0003682, GO:1901363
GO:0048384 [BP]	retinoic acid receptor signaling pathway	probable	GO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0000122 [BP]	negative regulation of transcription from RNA polymerase II promoter	probable	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0019048 [BP]	virus-host interaction	probable	GO:0044419, GO:0044703, GO:0000003, GO:0009987, GO:0022415, GO:0022414, GO:0044764, GO:0008150, GO:0016032, GO:0044403, GO:0051701, GO:0051704
GO:0046966 [MF]	thyroid hormone receptor binding	probable	GO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0000790 [CC]	nuclear chromatin	probable	GO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0003690 [MF]	double-stranded DNA binding	probable	GO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0046982 [MF]	protein heterodimerization activity	probable	GO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0042974 [MF]	retinoic acid receptor binding	probable	GO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0030424 [CC]	axon	probable	GO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0030375 [MF]	thyroid hormone receptor coactivator activity	probable	GO:0030545, GO:0030546, GO:0003713, GO:0003712, GO:0030374, GO:0003674, GO:0000989, GO:0000988, GO:0010861
GO:0042809 [MF]	vitamin D receptor binding	probable	GO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0070644 [MF]	vitamin D response element binding	probable	GO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0001701 [BP]	in utero embryonic development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0001893 [BP]	maternal placenta development	probable	GO:0060135, GO:0007275, GO:0044699, GO:0000003, GO:0048513, GO:0044706, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0044767, GO:0022414, GO:0008150, GO:0001890, GO:0051704, GO:0044703, GO:0044702, GO:0044707, GO:0003006, GO:0007565, GO:0048856, GO:0048731
GO:0045944 [BP]	positive regulation of transcription from RNA polymerase II promoter	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0035357 [BP]	peroxisome proliferator activated receptor signaling pathway	probable	GO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0007596 [BP]	blood coagulation	probable	GO:0032501, GO:0007599, GO:0044707, GO:0050878, GO:0050896, GO:0009611, GO:0042060, GO:0006950, GO:0050817, GO:0008150, GO:0065007, GO:0065008, GO:0044699
GO:0033159 [BP]	negative regulation of protein import into nucleus, translocation	probable	GO:0033157, GO:0070201, GO:0032879, GO:0060341, GO:0051051, GO:1900180, GO:0051049, GO:0032386, GO:0032387, GO:0090317, GO:0033158, GO:0050794, GO:0008150, GO:0065007, GO:0046822, GO:0048519, GO:0042306, GO:0051223, GO:0051224, GO:0050789, GO:0032880
GO:0031103 [BP]	axon regeneration	probable	GO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0048678, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0051716, GO:0000904, GO:0000902, GO:0048869, GO:0031099, GO:0009611, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0031102, GO:0030182, GO:0009987, GO:0044767, GO:0006950, GO:0044763, GO:0007409, GO:0048731, GO:0022008, GO:0048858, GO:0048699, GO:0032990, GO:0007399, GO:0050896, GO:0048856, GO:0048812, GO:0033554, GO:0008150
GO:0006591 [BP]	ornithine metabolic process	probable	GO:0044238, GO:0044710, GO:0009987, GO:1901564, GO:0006082, GO:0044237, GO:0006520, GO:0019752, GO:0071704, GO:0006807, GO:0008150, GO:0044281, GO:0008152, GO:0043436, GO:1901605
GO:0010269 [BP]	response to selenium ion	probable	GO:0042221, GO:0050896, GO:0010035, GO:0008150
GO:0007494 [BP]	midgut development	probable	GO:0032502, GO:0055123, GO:0032501, GO:0048565, GO:0044707, GO:0048856, GO:0044767, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0001972 [MF]	retinoic acid binding	probable	GO:0043168, GO:0031406, GO:0019840, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0033293, GO:0005501
GO:0008285 [BP]	negative regulation of cell proliferation	probable	GO:0042127, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:2000189 [BP]	positive regulation of cholesterol homeostasis	probable	GO:0032846, GO:2000188, GO:0032844, GO:0065007, GO:0048518, GO:0008150, GO:0050789
GO:0044255 [BP]	cellular lipid metabolic process	probable	GO:0044238, GO:0044710, GO:0006629, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152
GO:0001889 [BP]	liver development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0061008, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0060978 [BP]	angiogenesis involved in coronary vascular morphogenesis	probable	GO:0032502, GO:0007507, GO:0009653, GO:0044707, GO:0048513, GO:0001568, GO:0048856, GO:0001944, GO:0048731, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0044699, GO:0060976, GO:0060977, GO:0008150, GO:0001525, GO:0007275, GO:0048646, GO:0032501
GO:0043065 [BP]	positive regulation of apoptotic process	probable	GO:0050794, GO:0050789, GO:0048518, GO:0043067, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0048598 [BP]	embryonic morphogenesis	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0009653, GO:0007275, GO:0044699
GO:0019216 [BP]	regulation of lipid metabolic process	probable	GO:0008150, GO:0065007, GO:0080090, GO:0019222, GO:0050789
GO:0060485 [BP]	mesenchyme development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0048566 [BP]	embryonic digestive tract development	probable	GO:0032502, GO:0055123, GO:0032501, GO:0048565, GO:0044707, GO:0048568, GO:0048856, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0007164 [BP]	establishment of tissue polarity	probable	GO:0032502, GO:0048856, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0006637 [BP]	acyl-CoA metabolic process	probable	GO:0035383, GO:0051186, GO:0006732, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152, GO:0006793
GO:0031344 [BP]	regulation of cell projection organization	probable	GO:0008150, GO:0050794, GO:0065007, GO:0050789, GO:0051128
GO:0071729 [BP]	beak morphogenesis	probable	GO:0032502, GO:0071728, GO:0048856, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0016290 [MF]	palmitoyl-CoA hydrolase activity	probable	GO:0016787, GO:0016289, GO:0016790, GO:0016788, GO:0003824, GO:0003674, GO:0047617
GO:0043401 [BP]	steroid hormone mediated signaling pathway	probable	GO:0071383, GO:0023052, GO:0007165, GO:0070887, GO:0042221, GO:0050789, GO:0044699, GO:0009755, GO:0051716, GO:0033993, GO:0071310, GO:0065007, GO:0014070, GO:0071495, GO:0009719, GO:0009987, GO:0071396, GO:0050794, GO:0032870, GO:0044763, GO:0007154, GO:0010033, GO:0044700, GO:0071407, GO:0050896, GO:0009725, GO:0008150, GO:0048545
GO:0006805 [BP]	xenobiotic metabolic process	probable	GO:0051716, GO:0008152, GO:0050896, GO:0009987, GO:0044763, GO:0009410, GO:0044237, GO:0071466, GO:0008150, GO:0070887, GO:0042221, GO:0044699
GO:0001764 [BP]	neuron migration	probable	GO:0040011, GO:0032502, GO:0048699, GO:0048856, GO:0044707, GO:0007399, GO:0048870, GO:0009987, GO:0048869, GO:0032501, GO:0030154, GO:0006928, GO:0008150, GO:0051674, GO:0044763, GO:0007275, GO:0048731, GO:0022008, GO:0016477, GO:0051179, GO:0044699
GO:0006367 [BP]	transcription initiation from RNA polymerase II promoter	probable	GO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0006366, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0006352, GO:0019438
GO:0019899 [MF]	enzyme binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0045471 [BP]	response to ethanol	probable	GO:1901700, GO:0050896, GO:0008150, GO:0042221, GO:0097305, GO:0010033
GO:0001077 [MF]	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription	probable	GO:0003700, GO:0001228, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0032403 [MF]	protein complex binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0060687 [BP]	regulation of branching involved in prostate gland morphogenesis	probable	GO:0060688, GO:0022603, GO:0050793, GO:2000241, GO:0008150, GO:2000026, GO:2000027, GO:0051239, GO:0065007, GO:0050789
GO:0051384 [BP]	response to glucocorticoid stimulus	probable	GO:0009719, GO:0033993, GO:0031960, GO:0050896, GO:0008150, GO:0048545, GO:0009725, GO:0042221, GO:0010033, GO:0014070
GO:0055012 [BP]	ventricular cardiac muscle cell differentiation	probable	GO:0030154, GO:0072359, GO:0072358, GO:0051146, GO:0061061, GO:0007275, GO:0044699, GO:0048869, GO:0008150, GO:0048513, GO:0032502, GO:0032501, GO:0055007, GO:0009987, GO:0035051, GO:0009888, GO:0044767, GO:0044763, GO:0007507, GO:0044707, GO:0048856, GO:0014706, GO:0048738, GO:0060537, GO:0048731, GO:0042692
GO:0055010 [BP]	ventricular cardiac muscle tissue morphogenesis	probable	GO:0014706, GO:0072358, GO:0003229, GO:0061061, GO:0009653, GO:0007275, GO:0044699, GO:0003205, GO:0007517, GO:0003206, GO:0003208, GO:0048513, GO:0048729, GO:0048644, GO:0032502, GO:0009887, GO:0032501, GO:0055008, GO:0009888, GO:0003007, GO:0008150, GO:0003231, GO:0007507, GO:0044707, GO:0048856, GO:0072359, GO:0048738, GO:0044767, GO:0060537, GO:0048731, GO:0060415
GO:0045216 [BP]	cell-cell junction organization	probable	GO:0034330, GO:0009987, GO:0016043, GO:0044763, GO:0044699, GO:0008150, GO:0071840
GO:0033189 [BP]	response to vitamin A	probable	GO:0009991, GO:0009605, GO:0033993, GO:0007584, GO:0031667, GO:0050896, GO:0033273, GO:0008150, GO:0042221, GO:0010033
GO:0045930 [BP]	negative regulation of mitotic cell cycle	probable	GO:0007346, GO:0045786, GO:0051726, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0061032 [BP]	visceral serous pericardium development	probable	GO:0032502, GO:0007507, GO:0048856, GO:0060039, GO:0044707, GO:0048513, GO:0032501, GO:0060429, GO:0009888, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0045596 [BP]	negative regulation of cell differentiation	probable	GO:0051093, GO:0050793, GO:0050794, GO:0008150, GO:0045595, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0003705 [MF]	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity	probable	GO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0003707 [MF]	steroid hormone receptor activity	probable	GO:0003674, GO:0038023, GO:0004872, GO:0004871, GO:0060089
GO:0060395 [BP]	SMAD protein signal transduction	probable	GO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0048589 [BP]	developmental growth	probable	GO:0044767, GO:0032502, GO:0008150, GO:0040007, GO:0044699
GO:0071300 [BP]	cellular response to retinoic acid	probable	GO:1901700, GO:1901701, GO:0032526, GO:0033993, GO:0050896, GO:0009987, GO:0071396, GO:0051716, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0019904 [MF]	protein domain specific binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0043433 [BP]	negative regulation of sequence-specific DNA binding transcription factor activity	probable	GO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0044092, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0065009, GO:0051252, GO:0010468
GO:0007566 [BP]	embryo implantation	probable	GO:0032502, GO:0044703, GO:0044702, GO:0000003, GO:0044707, GO:0044706, GO:0007565, GO:0022414, GO:0032501, GO:0008150, GO:0007275, GO:0044699, GO:0051704
GO:0006954 [BP]	inflammatory response	probable	GO:0006952, GO:0050896, GO:0006950, GO:0008150, GO:0009611
GO:0042803 [MF]	protein homodimerization activity	probable	GO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0007422 [BP]	peripheral nervous system development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0006766 [BP]	vitamin metabolic process	probable	GO:0044710, GO:0008150, GO:0044281, GO:0008152
GO:0030900 [BP]	forebrain development	probable	GO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0035108 [BP]	limb morphogenesis	probable	GO:0032502, GO:0048856, GO:0044707, GO:0060173, GO:0035107, GO:0044767, GO:0032501, GO:0008150, GO:0044699, GO:0009653, GO:0007275, GO:0048736
GO:0023019 [BP]	signal transduction involved in regulation of gene expression	probable	GO:0044700, GO:0051716, GO:0019222, GO:0008150, GO:0060255, GO:0050896, GO:0009987, GO:0050794, GO:0050789, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0010468, GO:0044699
GO:0007519 [BP]	skeletal muscle tissue development	probable	GO:0032502, GO:0007517, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0044767, GO:0061061, GO:0014706, GO:0048513, GO:0008150, GO:0060537, GO:0060538, GO:0048731, GO:0007275, GO:0044699
GO:0033280 [BP]	response to vitamin D	probable	GO:1901700, GO:0009991, GO:0009605, GO:0033993, GO:0007584, GO:0031667, GO:0050896, GO:0033273, GO:0008150, GO:0042221, GO:0097305, GO:0010033, GO:0014070
GO:0060528 [BP]	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	probable	GO:0048610, GO:0061458, GO:0030154, GO:0032501, GO:0007275, GO:0044699, GO:0000003, GO:0048869, GO:0060525, GO:0060742, GO:0030850, GO:0048513, GO:0030855, GO:0002067, GO:0002065, GO:0032502, GO:0060429, GO:0048608, GO:0009987, GO:0009888, GO:0044767, GO:0022414, GO:0008150, GO:0001655, GO:0044707, GO:0003006, GO:0048856, GO:0044763, GO:0048731, GO:0048732
GO:0042524 [BP]	negative regulation of tyrosine phosphorylation of Stat5 protein	probable	GO:0010563, GO:0019220, GO:0080090, GO:0019222, GO:0048585, GO:0031324, GO:0048583, GO:0023057, GO:0010648, GO:0023051, GO:0009892, GO:0010646, GO:0010627, GO:0050789, GO:0051248, GO:0010605, GO:0009968, GO:0009966, GO:0045936, GO:0051246, GO:0042532, GO:0065007, GO:0031399, GO:0048519, GO:0010741, GO:0042325, GO:0046426, GO:0046425, GO:0060255, GO:0031323, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0042509, GO:0042522, GO:0032269, GO:0042326, GO:0050730, GO:0031400, GO:0050732, GO:0001933, GO:0001932, GO:0048523
GO:0005667 [CC]	transcription factor complex	probable	GO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0060038 [BP]	cardiac muscle cell proliferation	probable	GO:0055017, GO:0072359, GO:0072358, GO:0035265, GO:0007275, GO:0044699, GO:0040007, GO:0033002, GO:0048513, GO:0032502, GO:0032501, GO:0008283, GO:0009888, GO:0044767, GO:0008150, GO:0007507, GO:0044707, GO:0048856, GO:0014706, GO:0048738, GO:0060419, GO:0060537, GO:0048731, GO:0014855
GO:0060838 [BP]	lymphatic endothelial cell fate commitment	probable	GO:0030154, GO:0072359, GO:0072358, GO:0045446, GO:0007275, GO:0044699, GO:0003158, GO:0001944, GO:0001945, GO:0008150, GO:0060836, GO:0030855, GO:0060839, GO:0032502, GO:0009987, GO:0032501, GO:0060429, GO:0009888, GO:0044767, GO:0044763, GO:0072148, GO:0045165, GO:0044707, GO:0048856, GO:0048869, GO:0048731
GO:0000980 [MF]	RNA polymerase II distal enhancer sequence-specific DNA binding	probable	GO:0005488, GO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001158, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363, GO:0035326
GO:0005737 [CC]	cytoplasm	probable	GO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0045736 [BP]	negative regulation of cyclin-dependent protein serine/threonine kinase activity	probable	GO:0033673, GO:0043549, GO:0019220, GO:0080090, GO:0019222, GO:0044092, GO:0031324, GO:0031323, GO:0009892, GO:0071901, GO:0071900, GO:0043086, GO:0051248, GO:0045786, GO:0051348, GO:0051246, GO:0050789, GO:0065007, GO:0031399, GO:0048519, GO:0065009, GO:0006469, GO:0045936, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0010605, GO:0042325, GO:0032269, GO:0042326, GO:0050790, GO:0051726, GO:0010563, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0000079, GO:0048523
GO:0055088 [BP]	lipid homeostasis	probable	GO:0042592, GO:0008150, GO:0065008, GO:0065007, GO:0048878
GO:0005504 [MF]	fatty acid binding	probable	GO:0043168, GO:0031406, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0033293
GO:0007568 [BP]	aging	probable	GO:0044767, GO:0032502, GO:0008150, GO:0044699
GO:0051094 [BP]	positive regulation of developmental process	probable	GO:0050793, GO:0048518, GO:0065007, GO:0050789, GO:0008150
GO:0030308 [BP]	negative regulation of cell growth	probable	GO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0021575 [BP]	hindbrain morphogenesis	probable	GO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0030902, GO:0048731, GO:0009653, GO:0007275, GO:0044699, GO:0007417
GO:0032869 [BP]	cellular response to insulin stimulus	probable	GO:0070887, GO:0032868, GO:0044699, GO:0009719, GO:0051716, GO:0071375, GO:0071417, GO:0071310, GO:0071495, GO:0009987, GO:0032870, GO:0044763, GO:0010243, GO:0042221, GO:0043434, GO:0010033, GO:1901700, GO:1901701, GO:0009725, GO:0050896, GO:1901699, GO:1901652, GO:1901653, GO:0008150, GO:1901698
GO:0008270 [MF]	zinc ion binding	probable	GO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872
GO:0008203 [BP]	cholesterol metabolic process	probable	GO:0044238, GO:0044710, GO:0016125, GO:0008202, GO:0006629, GO:0006066, GO:0071704, GO:0008150, GO:0044281, GO:0008152, GO:1901360, GO:1901615

Prediction of Enzyme Commission Number

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction